tirzepatide and sleep Diabetes drug resolves apnea in up to 52% of patients—is FDA approval in the cards? What clinicians should know about

Now, we are entering the second phase of the GLP-1 consumer journey: Reinvention Mode

Common side effects: Dry mouth, constipation, difficulty sleeping, dizziness, altered taste and tingling sensations (paresthesia)

Oral Formulations Currently, all approved incretin medications require injection because the peptide molecules break down in your digestive system

Water-soluble compounds can be safely transported through the blood to the kidneys or the bile, where they are eventually excreted from the body

We may also have new therapies to complement or even supersede GLP-1 drugs as researchers are investigating other pharmaceutical avenues for weight loss